Search results
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Clinical Trials Arena via Yahoo Finance· 5 hours agoA long-acting antibody, sipavibart was assessed in the trial as Covid-19 pre-exposure prophylaxis...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 1 day agoResults from the phase 3 SUPERNOVA study show that the company’s investigational long-acting ...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 1 day agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Long Covid: the cause, the consequence, the future of clinical trials
Clinical Trials Arena via Yahoo Finance· 1 day agoImperial College London hopes its recently published Long Covid study will lead to further clinical...
Chronic Lyme Disease: Why COVID May Spark Better Tests and Treatment
Well and Good· 2 days agoPeople with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but...
Long Dismissed, Chronic Lyme Is Finally in the Spotlight
Time via AOL· 19 hours agoIn addition, Akiko Iwasaki, an immunobiologist at the Yale University School of ...real,” Aucott...
Sanofi boosts French biomanufacturing with €1 billion investment
Investing.com· 4 days agoSanofi (EPA: SASY ) (NASDAQ: SNY ), a global biopharmaceutical company, announced today a...
Earnings call: Invivyd optimistic about PEMGARDA's market potential
Investing.com· 4 days agoInvivyd is committed to expanding its product offerings and is working on securing reimbursement and...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoDuring the March quarter, the U....Paxlovid still beat sales forecasts. Notably, revenue from the...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 4 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...